rs199476325
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 4P and 5B. PM1PP3_ModerateBS1_SupportingBS2
The NM_033337.3(CAV3):c.100G>A(p.Glu34Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0000256 in 1,601,948 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_033337.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151984Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251124Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135758
GnomAD4 exome AF: 0.0000269 AC: 39AN: 1449846Hom.: 0 Cov.: 28 AF XY: 0.0000291 AC XY: 21AN XY: 722100
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152102Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74356
ClinVar
Submissions by phenotype
Rippling muscle disease 2 Pathogenic:1
- -
Cardiomyopathy Uncertain:1
- -
Long QT syndrome Uncertain:1
This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 34 of the CAV3 protein (p.Glu34Lys). This variant is present in population databases (rs199476325, gnomAD 0.005%). This missense change has been observed in individuals with limb-girdle muscular dystrophy (LGMD) (PMID: 17897828, 27854218). This variant is also known as p.Glu33Lys. ClinVar contains an entry for this variant (Variation ID: 31730). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C15"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Cardiovascular phenotype Uncertain:1
The c.100G>A (p.E34K) alteration is located in exon 1 (coding exon 1) of the CAV3 gene. This alteration results from a G to A substitution at nucleotide position 100, causing the glutamic acid (E) at amino acid position 34 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at